Business Segments · Goodwill acquired

Oncology & Multispecialty — Goodwill acquired

Analysis

StatementSegment
CategoryGrowth
SignalContext dependent
VolatilityVolatile
First reportedQ1 2025
Last reportedQ3 2026Feb 4, 2026
Rolls up toGoodwill Additions

How to read this metric

Higher values indicate aggressive expansion or consolidation within the specialty healthcare market.

Detailed definition

The premium paid over the fair value of net identifiable assets during an acquisition within the oncology and multispeci...

Peer comparison

Standard M&A disclosure found in the 'Acquisitions' or 'Goodwill' notes of financial statements.

Metric ID: mck_segment_oncology_multispecialty_goodwill_acquired

Historical Data

5 periods
 Q1 '25Q2 '25Q3 '25Q4 '25Q3 '26
Value$0.00$0.00$0.00$0.00$28.00M
Range$0.00 – $28.00M

Similar Metrics at Other Companies

IR
Ingersoll RandIRView metric
Centene logo
CenteneCNCView metric
IR
Ingersoll RandIRView metric
Centene logo
CenteneCNCView metric
Markel logo
MarkelMKLView metric
Cognizant logo
CognizantCTSHView metric

Frequently Asked Questions

What is McKesson's oncology & multispecialty — goodwill acquired?
McKesson (MCK) reported oncology & multispecialty — goodwill acquired of $28.00M in Q4 2025.
What does oncology & multispecialty — goodwill acquired mean?
The amount of goodwill added through new business acquisitions.